Sugi Predict

Sugi Predict / Compounds / SCHEMBL2923249

SCHEMBL2923249

SCHEMBL2923249

[CH2]Cc1ccc(C2CC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 11/20 0.42
▸ ESR1 P03372 6/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ SPHK1 Q9NYA1 5/20 0.42
▸ POLB P06746 1/20 0.39
▸ CYP2D6 P10635 1/20 0.37
▸ LSS P48449 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ SPHK2 Q9NRA0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL676292 0.91 HDAC8 (0.41) ESR2ESR1CYP3A4CYP2C9CYP2D6
SCHEMBL2919141 0.91 ESR2 (0.43) ESR2ESR1CYP3A4CYP2C9SPHK1
SCHEMBL330369 0.89 HAO1 (0.42) —
SCHEMBL676977 0.89 HAO1 (0.42) —
SCHEMBL9462616 0.83 ESR2 (0.40) ESR2ESR1CYP3A4CYP2C9SPHK1
SCHEMBL9462624 0.83 ESR2 (0.40) ESR2ESR1CYP3A4CYP2C9SPHK1
SCHEMBL28258195 0.78 HTR3A (0.59) —
SCHEMBL2884020 0.78 ESR2 (0.57) ESR2ESR1CYP3A4CYP2C9POLB
SCHEMBL1405567 0.76 ESR2 (0.46) ESR2ESR1CYP3A4CYP2C9POLB
SCHEMBL16213455 0.75 ESR2 (0.42) ESR2ESR1CYP3A4CYP2C9SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017199103-A1 BENZAMIDE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-11-23 — — WO claimed
EP-3087060-A1 PYRIMIDONE CARBOXAMIDE COMPOUNDS AS PDE2 INHIBITORS Merck Sharp & Dohme Corp. (US) 2016-11-02 — — EP claimed
WO-2015096651-A1 PYRIMIDONE CARBOXAMIDE COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-07-02 — — WO claimed
US-6774212-B2 FOR THERAPY OF VIRAL INFECTION OR AS AN ASSAY STANDARD OR REAGENT BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-10 — — US claimed
US-6699855-B2 PYRROLOPYRAZINONES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2004-03-02 — — US claimed
US-20020123468-A1 Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-05 — — US claimed
CN-113660983-A Carbamate derivatives and uses thereof 诺瑟拉有限公司 2021-11-16 — — CN disclosed
US-10959432-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2021-03-30 — — US disclosed
US-10757941-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-09-01 — — US disclosed
US-20200267986-A1 Microbiocidal Oxadiazole Derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-08-27 — — US disclosed
US-10687533-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-06-23 — — US disclosed
EP-3439477-B1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-05-06 — — EP disclosed
US-20190274304-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-09-12 — — US disclosed
EP-1367439-A1 Radiation-sensitive composition FUJI PHOTO FILM CO., LTD. (JP) 2003-12-03 — — EP disclosed
US-6630280-B1 Resin and compound that generates an arylsulfonic acid when exposed to actinic radiation; sensitivity; resolution; smoothness FUJI PHOTO FILM CO., LTD. (JP) 2003-10-07 — — US disclosed
US-20030134221-A1 Positive resist composition FUJI PHOTO FILM CO., LTD. 2003-07-17 — — US disclosed
US-20030108811-A1 Positive resist composition FUJI PHOTO FILM CO., LTD. 2003-06-12 — — US disclosed
US-20020123468-A1 Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-05 — — US disclosed
US-20020065248-A1 Inhibitors of hepatitis C virus NS3 protease BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-05-30 — — US disclosed
US-20020012866-A1 Positive photoresist composition FUJIFILM CORPORATION (JP) 2002-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020065248-A1 Inhibitors of hepatitis C virus NS3 protease TMPRSS15, CTRC, CPN1 ESR2 880/4885ESR1 1023/4885CYP3A4 421/4885
US-10959432-B2 Microbiocidal oxadiazole derivatives PRF1, NOX1, ARG1 ESR2 3075/4885ESR1 3487/4885CYP3A4 141/4885
US-10687533-B2 Microbiocidal oxadiazole derivatives PRF1, NOX1, ARG1 ESR2 3075/4885ESR1 3487/4885CYP3A4 141/4885
US-10757941-B2 Microbiocidal oxadiazole derivatives PRF1, NOX1, ARG1 ESR2 3104/4885ESR1 3517/4885CYP3A4 137/4885
US-20200267986-A1 Microbiocidal Oxadiazole Derivatives PRF1, NOX1, ARG1 ESR2 3075/4885ESR1 3487/4885CYP3A4 141/4885
US-20190274304-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES PRF1, NOX1, ARG1 ESR2 3104/4885ESR1 3517/4885CYP3A4 137/4885
US-20020123468-A1 Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease CES1, CYP51A1, SPINT2 ESR2 3559/4885ESR1 4224/4885CYP3A4 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.